Studies on the mechanism of cardiotonics with reference to cardiac glycoside, calcium ion and myocardial catecholamine in the canine heart.
D000818:Animals; D001022:Aortic Valve Insufficiency; D002118:Calcium / Q000494:pharmacology*; D006332:Cardiomegaly; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000502:physiology*; D004285:Dogs; D004357:Drug Synergism; D004558:Electric Stimulation; D006146:Guanidines / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008854:Microscopy, Electron; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013328:Strophanthins / Q000494:pharmacology*; D013696:Temperature; D013997:Time Factors
D002395:Catecholamines; D006146:Guanidines; D013328:Strophanthins; D012110:Reserpine; D011433:Propranolol; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine